January 22, 2015

Chr. Hansen reports 9% revenue growth for Q1 2014/15

Chr. Hansen reported a revenue of EUR 188 million for Q1 2014/2015, up 10% on Q1 2013/14, and an organic revenue growth of 9% for the quarter.

"The Cultures & Enzymes Division (7% organic growth) performed in line with our long-term expectations and the Health & Nutrition Division (29%) delivered very strong growth albeit on weak comparables. The Natural Colors Division (4%) grew below expectation.

The implementation of our Nature's No. 1 strategy continues. We have accelerated our research and development efforts within biological plant protection and we have strengthened the organisation in China to support our new go-to-market strategy for cultures and enzymes," said CEO Cees de Jong.
 
Organic revenue growth for 2014/15 is expected to be 7-9%.

Details of the interim report are available here.